299 related articles for article (PubMed ID: 12091330)
1. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Flowers ME; Parker PM; Johnston LJ; Matos AV; Storer B; Bensinger WI; Storb R; Appelbaum FR; Forman SJ; Blume KG; Martin PJ
Blood; 2002 Jul; 100(2):415-9. PubMed ID: 12091330
[TBL] [Abstract][Full Text] [Related]
2. Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia.
Elmaagacli AH; Basoglu S; Peceny R; Trenschel R; Ottinger H; Lollert A; Runde V; Grosse-Wilde H; Beelen DW; Schaefer UW
Blood; 2002 Feb; 99(4):1130-5. PubMed ID: 11830457
[TBL] [Abstract][Full Text] [Related]
3. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
6. Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcome.
Barge RM; Brouwer RE; Beersma MF; Starrenburg CW; Zwinderman AH; Hale G; Waldmann H; den Ottolander GJ; Falkenburg JH; Willemze R; Fibbe WE
Bone Marrow Transplant; 2001 May; 27(10):1053-8. PubMed ID: 11438820
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
8. Outcome of transplantation of highly purified peripheral blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase chronic myeloid leukemia.
Elmaagacli AH; Peceny R; Steckel N; Trenschel R; Ottinger H; Grosse-Wilde H; Schaefer UW; Beelen DW
Blood; 2003 Jan; 101(2):446-53. PubMed ID: 12393406
[TBL] [Abstract][Full Text] [Related]
9. Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial.
Schmitz N; Beksac M; Bacigalupo A; Ruutu T; Nagler A; Gluckman E; Russell N; Apperley J; Szerm J; Bradstock K; Buzyn A; Schlegelberger B; Matcham J; Gratwohl A
Haematologica; 2005 May; 90(5):643-8. PubMed ID: 15921379
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
[TBL] [Abstract][Full Text] [Related]
11. [PBSCT and GVHD].
Hino M; Yamane T; Ohta K; Tatsumi N
Rinsho Byori; 1999 May; Suppl 110():92-8. PubMed ID: 10475037
[TBL] [Abstract][Full Text] [Related]
12. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
Cutler C; Giri S; Jeyapalan S; Paniagua D; Viswanathan A; Antin JH
J Clin Oncol; 2001 Aug; 19(16):3685-91. PubMed ID: 11504750
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
Konuma T; Miyao K; Nakasone H; Ouchi F; Fukuda T; Tanaka M; Ozawa Y; Ota S; Kawakita T; Uchida N; Sawa M; Katayama Y; Hiramoto N; Eto T; Ichinohe T; Atsuta Y; Kanda J;
Cytotherapy; 2024 Mar; ():. PubMed ID: 38639671
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Oehler VG; Radich JP; Storer B; Blume KG; Chauncey T; Clift R; Snyder DS; Forman SJ; Flowers ME; Martin P; Guthrie KA; Negrin RS; Appelbaum FR; Bensinger W
Biol Blood Marrow Transplant; 2005 Feb; 11(2):85-92. PubMed ID: 15682068
[TBL] [Abstract][Full Text] [Related]
16. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study.
Blau IW; Basara N; Lentini G; Guenzelmann S; Kirsten D; Schmetzer B; Bischoff M; Roemer E; Kiehl MG; Fauser AA
Bone Marrow Transplant; 2001 Jan; 27(1):27-33. PubMed ID: 11244435
[TBL] [Abstract][Full Text] [Related]
18. Possible clinical benefits of the use of peripheral blood stem cells over bone marrow in the allogeneic transplantation setting for the treatment of childhood leukemia.
Matsubara H; Makimoto A; Takayama J; Higa T; Saito T; Kanda Y; Tanosaki R; Mineishi S; Ohira M; Takaue Y
Jpn J Clin Oncol; 2001 Jan; 31(1):30-4. PubMed ID: 11256838
[TBL] [Abstract][Full Text] [Related]
19. Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
Lickliter JD; McGlave PB; DeFor TE; Miller JS; Ramsay NK; Verfaillie CM; Burns LJ; Wagner JE; Eastlund T; Dusenbery K; Weisdorf DJ
Bone Marrow Transplant; 2000 Oct; 26(7):723-8. PubMed ID: 11042652
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study.
Mohty M; Kuentz M; Michallet M; Bourhis JH; Milpied N; Sutton L; Jouet JP; Attal M; Bordigoni P; Cahn JY; Boiron JM; Blaise D;
Blood; 2002 Nov; 100(9):3128-34. PubMed ID: 12384409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
